To retrospectively evaluate the efficacy and safety of unilateral and bilateral percutaneous balloon kyphoplasty (PKP) in the treatment of osteoporotic thoracolumbar burst fractures. Retrospectively collected clinical data of 138 patients with osteoporotic thoracolumbar burst fractures who underwent unilateral (n = 70) and bilateral (n = 68) PKP in our hospital from March 2015 to December 2018. The general conditions, operation time, radiation exposure time, intraoperative blood loss, bone cement dosage, hospitalization expenses, and complications were collected from the two groups. Visual analog scale (VAS) values, Cobb's angle changes, average vertebral height changes, and Oswestry Dysfunction Index (ODI) values before treatment, 1 month, and 6 months after treatment were collected. There was no significant difference in gender (male: 28 vs 22; female 42 vs 46) and age (70.25 ± 7.10 vs 69.82 ± 8.20, P > .05) distribution between the two groups. The VAS score (7.38 ± 1.34 vs 2.52 ± 0.99, P < .05), ODI (77.24 ± 6.98 vs 23.11 ± 3.54, P < .05), vertebral mean height (16.71 ± 2.18 vs 17.05 ± 1.94, P < .05) and Cobb's angle (20.26 ± 3.21 vs 11.58 ± 3.20, P < .05) of the two groups were significantly improved after operation, but there was no significant difference between the two groups ( P > .05). There was no significant difference in the rate of cement leakage (10.29% vs 11.42%, P > .05), incision swelling (30.88% vs 19.71%, P > .05) and incidence of adjacent vertebrae (4.41% vs 5.71%, P > .05) between the two groups. Compared with bilateral PKP group, operation time (50.88 ± 7.38 vs 62.18 ± 8.01), intraoperative blood loss (14.54 ± 3.16 vs 22.03 ± 5.92), radiation exposure time (23.74 ± 3.41 vs 15.22 ± 3.70), bone cement dosage (4.36 ± 0.81 vs 5.16 ± 0.77) and hospitalization costs (2.38 ± 0.08 vs 2.74 ± 0.07) were significantly lower in the unilateral PKP group ( P < .05). Bilateral PKP and unilateral PKP have the same efficacy and safety in the treatment of osteoporotic thoracolumbar burst fractures. However, the unilateral PKP has the characteristics of short operation time, small trauma, low cost and short radiation exposure time, and has clinical application value.
Author name ambiguity causes inadequacy and inconvenience in academic information retrieval, which raises the necessity of author name disambiguation (AND). Existing AND methods can be divided into two categories: the models focusing on content information to distinguish whether two papers are written by the same author, the models focusing on relation information to represent information as edges on the network and to quantify the similarity among papers. However, the former requires adequate labeled samples and informative negative samples, and are also ineffective in measuring the high-order connections among papers, while the latter needs complicated feature engineering or supervision to construct the network. We propose a novel generative adversarial framework to grow the two categories of models together: (i) the discriminative module distinguishes whether two papers are from the same author, and (ii) the generative module selects possibly homogeneous papers directly from the heterogeneous information network, which eliminates the complicated feature engineering. In such a way, the discriminative module guides the generative module to select homogeneous papers, and the generative module generates high-quality negative samples to train the discriminative module to make it aware of high-order connections among papers. Furthermore, a self-training strategy for the discriminative module and a random walk based generating algorithm are designed to make the training stable and efficient. Extensive experiments on two real-world AND benchmarks demonstrate that our model provides significant performance improvement over the state-of-the-art methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.